CD133 has also been used as a marker for colorectal carcinoma stem cells, whereas other studies demonstrated that such cells could be identified by expression of either EpCAM or CD44 or a combination of EpCAM, CD44 and CD166 or ALDH1 (for review, see [121]). This evidence concerns the gene EPCAM and colorectal carcinoma.